Gritstone bio Management
Management criteria checks 2/4
Gritstone bio's CEO is Celia Economides, appointed in Jun 2021, has a tenure of 3.58 years. directly owns 0.056% of the company’s shares, worth $618.49. The average tenure of the management team and the board of directors is 3.6 years and 5.8 years respectively.
Key information
Celia Economides
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.06% |
| Management average tenure | 3.6yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation
Jun 11
Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering
Apr 07Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%
Aug 14Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst
Sep 26Gritstone reaches six-month high on publication of data for cancer vaccine
Aug 16Gritstone bio announces $80M credit facility
Jul 21Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?
Jul 07Gritstone bio: Potential To Advance Colorectal Cancer Treatment
Jul 05Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation
Jun 14Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates
Mar 17We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate
Mar 05Gritstone: Why The Stock Fell On Positive Data
Jan 18CEO
Celia Economides (43 yo)
3.6yrs
Tenure
Ms. Vassiliki Economides, also known as Celia, is the Interim Chief Executive Officer at Gritstone bio, Inc since December 31, 2024 and was its Executive Vice President until December 31, 2024. She is the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim Chief Executive Officer and Chief Financial Officer | 3.6yrs | no data | 0.056% $ 618.5 | |
| Chief Accounting Officer | 4yrs | no data | 0.056% $ 620.3 | |
| Director of Investor Relations & Corporate Communications | no data | no data | no data | |
| Executive VP & Chief People Officer | 3.5yrs | no data | no data |
3.6yrs
Average Tenure
Experienced Management: GRTS.Q's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 5.3yrs | US$176.00k | no data | |
| Independent Director | less than a year | no data | 0.017% $ 187.6 | |
| Independent Director | 2.4yrs | US$132.50k | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Independent Director & Member of Scientific Advisory Board | 8.6yrs | US$140.00k | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Independent Director | 3.6yrs | US$138.50k | no data | |
| Independent Director | 3yrs | US$136.50k | no data |
5.8yrs
Average Tenure
63yo
Average Age
Experienced Board: GRTS.Q's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/07 00:41 |
| End of Day Share Price | 2025/01/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Gritstone bio, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Madhu Kumar | Baird |
| Corinne Johnson | Goldman Sachs |
| Douglas Buchanan | JMP Securities |